Non-caseating granulomata associated with hypocellular myelodysplastic syndrome

被引:3
作者
Ng, T [1 ]
Yeghen, T [1 ]
Pagliuca, A [1 ]
Gillett, DS [1 ]
Mufti, GJ [1 ]
机构
[1] Kings Coll Hosp London, Dept Haematol Med, London SE5 9RS, England
关键词
non-caseating granulomata; hypocellular myelodysplastic syndrome;
D O I
10.3109/10428190009065840
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Non-caseating granuloma (NCG) remains a histopathological hallmark for sarcoidosis. Although the exact mechanism for NCG formation is unknown, the pathogenesis may involve a disordered antigen presentation in the monocyte/macrophage system, functional abnormalities in activated T-lymphocytes and uncontrolled cytokine production. Similar immunological dysfunction has been described in myelodysplastic syndrome (MDS). However, the association of NCG and MDS is rarely documented. We report a case of hypocellular MDS associated with generalized NCG. Despite treatment for both sarcoidosis and tuberculosis, the patient failed to respond. A clonal myeloid disorder which was initially suppressed by T-cell immunosurveillance evolved after treatment with anti-thymocyte globulin. Although the coexistence of sarcoidosis remains a possibility, the lack of supportive clinical evidence of sarcoidosis, the abnormal appearances of the bone marrow, together with the failure to improve on high-dose steroid favour the clonal myeloid disorder as the sole pathology.
引用
收藏
页码:397 / +
页数:8
相关论文
共 20 条
[1]  
Brincker H, 1989, Sarcoidosis, V6, P31
[2]  
Crystal RG., 1994, HARRISONS PRINCIPLES, P1679
[3]   IMMUNOLOGICAL FINDINGS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME [J].
FELZMANN, T ;
GISSLINGER, H ;
LUDWIG, H .
LEUKEMIA & LYMPHOMA, 1994, 15 (3-4) :201-208
[4]  
GEARY CG, 1996, BRIT J HAEMATOL, V94, P579
[5]   IMMUNOLOGICAL ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES [J].
HAMBLIN, T .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1992, 6 (03) :571-586
[6]   Immunology of sarcoidosis [J].
Kataria, YP ;
Holter, JF .
CLINICS IN CHEST MEDICINE, 1997, 18 (04) :719-+
[7]   BONE-MARROW ANALYSIS OF THE MYELODYSPLASTIC SYNDROMES - HISTOLOGICAL AND IMMUNOHISTOCHEMICAL FEATURES RELATED TO THE EVOLUTION OF OVERT LEUKEMIA [J].
KITAGAWA, M ;
KAMIYAMA, R ;
TAKEMURA, T ;
KASUGA, T .
VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY, 1989, 57 (01) :47-53
[8]   Diagnostic criteria for hypocellular acute leukemia: A clinical entity distinct from overt acute leukemia and myelodysplastic syndrome [J].
Nagai, K ;
Kohno, T ;
Chen, YX ;
Tsushima, H ;
Mori, H ;
Nakamura, H ;
Jinnai, I ;
Matsuo, T ;
Kuriyama, K ;
Tomonaga, M ;
Bennett, JM .
LEUKEMIA RESEARCH, 1996, 20 (07) :563-574
[9]  
Nickerson DA, 1937, ARCH PATHOL, V24, P19
[10]   Clinical aspects, cytogenetics and disease evolution in myelodysplastic syndromes [J].
Ohyashiki, K ;
Ohyashiki, JH ;
Iwabuchi, A ;
Toyama, K .
LEUKEMIA & LYMPHOMA, 1996, 23 (5-6) :409-415